MAQUET CARDIOVASCULAR LLC

Manufacturer adverse-event records for MAQUET CARDIOVASCULAR LLC come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2008–2026 · mid-book · typical Death-code · injury-light

Injury-mix signature

MAQUET CARDIOVASCULAR LLC is lighter on Injury codes

Injury-coded event_type share is 7.9% (injury-light tercile) beside 0.17% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for MAQUET CARDIOVASCULAR LLC

The standout signal for MAQUET CARDIOVASCULAR LLC is Injury-mix: 7.9% Injury-coded (injury-light) beside 0.17% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for MAQUET CARDIOVASCULAR LLC. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Malfunction at 8,199 (91.8% of event_type total). Peak single-year volume reaches 1,423 reports across 19 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

8,931
Total Reports
15
Event-type Death
710
Injury Reports
20
Device Types

Event Types

Malfunction 8,199 (91.8%)
Injury 710 (7.9%)
Death 15 (0.2%)
7 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

8,153 (91.2%)
Required Intervention 668 (7.5%)
Other 77 (0.9%)
R 15 (0.2%)
Death 12 (0.1%)
Hospitalization 7 (0.1%)
Life Threatening 3 (0.0%)
L 2 (0.0%)
S 2 (0.0%)
Disability 2 (0.0%)
D 1 (0.0%)
O 1 (0.0%)

Yearly Trend

08
2008: 9
09
2009: 10
10
2010: 43
11
2011: 13
12
2012: 29
13
2013: 163
14
2014: 88
15
2015: 157
16
2016: 20
17
2017: 17
18
2018: 25
19
2019: 1,122
20
2020: 1,180
21
2021: 1,061
22
2022: 1,026
23
2023: 1,073
24
2024: 1,423
25
2025: 1,345
26
2026: 127